UBE4B and neuroblastoma: In neuroblastoma patient cohorts separated by treatment risk group, low UBE4B expression was associated with lower event-free and overall survival rates in patients with both low and intermediate risk neuroblastoma and in those with high-risk neuroblastoma (Figure 2A).